Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver

被引:118
|
作者
Gerbes, AL
Gülberg, V
Bilzer, M
Vogeser, M
机构
[1] Univ Munich, Klinikum Grosshadern, Dept Med 2, D-81377 Munich, Germany
[2] Univ Munich, Klinikum Grosshadern, Inst Clin Chem, D-8000 Munich, Germany
关键词
D O I
10.1136/gut.50.1.106
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims. Diagnosis of moderately impaired renal function is, of particular importance in patients with cirrhosis of the liver. Whereas patients with a markedly impaired glomerular filtration rate can be diagnosed easily by elevated serum creatinine concentrations, moderately reduced renal function may be missed by this conventional parameter. Recently, cystatin C has been suggested as a sensitive marker of renal function, independent of sex or muscle mass. Therefore, the aim of this study was to investigate the value of serum cystatin C concentration for the detection of moderately impaired renal function. Methods: Ninety seven inhospital patients with cirrhosis and a 24 hour creatinine clearance of at least 40 ml/min were investigated and divided into group 1 (creatinine clearance greater than or equal to 70 ml/min; n=55) and group 2 (creatinine clearance 40-69 ml/min; n=42). Results: Serum cystatin C concentrations (mean (SD): 1.31 (0.51) v 1.04 (0.34) mg/l (p=0.008)) and creatinine. concentrations (1.03 (0.52) v 0.86 (0.22) mg/100 ml (p=0.03)) were higher in group 2 than in group I; there was no significant difference in urea concentrations. Receiver-operator characteristics (ROC) revealed a differential diagnostic advantage of cystatin C over creatinine and urea. At cut off concentrations of 1.0 mg/l, 0.9 mg/100 ml, and 28 mg/100 ml, respectively, cystatin C, creatinine, and urea exhibited 69%, 45%, and 44% sensitivity (p <0.05). As patients with a small muscle mass or reduced physical activity could be particularly prone to overestimation of their renal function, separate analyses were performed for the subgroups of female and Child-Pugh class C patients, respectively. In both groups, discrimination between patients with moderately impaired and normal renal function was best with cystatin C. In female patients, sensitivity of cystatin C (77.8%) was superior (p <0.05) to that of creatinine (38.9%) and urea (41.2%). In Child-Pugh C patients, the ROC curve was significantly better for cystatin C than for creatinine. Conclusions: Serum cystatin C determination could be a valuable tool in patients with cirrhosis, particularly with Child-Pugh. class C or in female patients, for early diagnosis of moderately impaired renal function.
引用
收藏
页码:106 / 110
页数:5
相关论文
共 50 条
  • [31] Is serum cystatin-C a suitable marker of renal function in children?
    Zaffanello, Marco
    Franchini, Massimo
    Fanos, Vassilios
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2007, 37 (03): : 233 - 240
  • [32] Cystatin C as an Early Marker of Renal Dysfunction in Patients with Cirrhosis of Liver: A Cross-sectional Study
    Bhuyan, Bidyut
    Das, Jayanta
    Das, Monigopa
    Bhattacharya, D. K.
    Nath, Chandan
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (03) : BC1 - BC4
  • [33] SERUM CYSTATIN C AS AN ENDOGENOUS MARKER OF RENAL FUNCTION IN PATIENTS WITH MILD TO MODERATE IMPAIRED KIDNEY FUNCTION
    Bevc, Sebastjan
    Hojs, Radovan
    Ekart, Robert
    Gorenjak, Maksimiljan
    Pecovnik-Balon, Breda
    Puklavec, Ludvik
    NEPHROLOGY, 2005, 10 : A141 - A141
  • [34] Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function
    Hojs, Radovan
    Bevc, Sebastjan
    Ekart, Robert
    Gorenjak, Maksimiljan
    Puklavec, Ludvik
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (07) : 1855 - 1862
  • [35] Cystatin C as a marker of renal function immediately after liver transplantation
    Biancofiore, G
    Pucci, L
    Cerutti, E
    Penno, G
    Pardini, E
    Esposito, M
    Bindi, L
    Pelati, E
    Romanelli, A
    Triscornia, S
    Salvadorini, MP
    Stratta, C
    Lanfranco, G
    Pellegrini, G
    Del Prato, S
    Salizzoni, M
    Mosca, F
    Filipponi, F
    LIVER TRANSPLANTATION, 2006, 12 (02) : 285 - 291
  • [36] Cystatin C as a marker of renal function in patients with Fabry disease
    Feriozzi, S
    Barbey, F
    Di Vito, R
    Benistan, K
    Ricci, R
    Germain, DP
    ACTA PAEDIATRICA, 2006, 95 : 134 - 135
  • [37] Cystatin C as a marker of renal function in kidney transplant patients
    Mendiluce, A
    Bustamante, J
    Martin, D
    Santos, M
    Bustamante, R
    Pascual, P
    Jabary, NS
    Castañeda, A
    Muñoz, MF
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) : 3844 - 3847
  • [38] Serum cystatin C as an endogenous marker of renal function in patients with diabetes mellitus type 2
    Zavrsnik, M
    Bevc, S
    Gorenjak, M
    Puklavec, L
    Hojs, R
    DIABETES, 2004, 53 : A208 - A208
  • [39] Serum Cystatin C is a Potential Endogenous Marker for the Estimation of Renal Function in Male Gout Patients with Renal Impairment
    Choe, Jung-Yoon
    Park, Sung-Hoon
    Kim, Seong-Kyu
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2010, 25 (01) : 42 - 48
  • [40] Cystatin C!New marker of renal function
    Arias, IM
    Pobes, A
    Baños, M
    NEFROLOGIA, 2005, 25 (03): : 217 - 220